while 100% of my salary and all other compensations remain paid by Sanofi. The trade for Hemarina is to have a pharma background experienced competency ex gratia. It is ruled and governed by a ...

The current US Supreme Court has no fundamental understanding of a range of medical, engineering, technological, or ...

All lines have been placed on mute to prevent any background noise ... revenue as we delivered a substantial amount of product to Sanofi during the quarter. Excluding the ALDURAZYME revenue ...

Buyout firm Advent International is considering the sale of generic drugmaker Zentiva, in a deal that could value the former ...

For elderly people and those who already have chronic background diseases with weakened immunity, facing influenza can be self-threatening. On October 9, Sanofi and Vietnam Vaccine JSC (VNVC), the ...

Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Good morning, and welcome to Fulcrum Therapeutics Third Quarter ...

Over 2 decades ago, the aldosterone antagonist eplerenone proved beneficial after MI complicated by left ventricular ...

Q3 2025 Earnings Conference Call November 20, 2024 5:00 PM ETCompany ParticipantsJimmy Sexton - Head of IRSridhar Ramaswamy ...

Revenues in the fiscal second quarter of 2025 decreased 3% to $201,000, largely due to decreased sales to veterinary clinics. The decrease was partially offset by a 24% increase in sales to ...

ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company ...

11 University of Pennsylvania, Division of Epidemiology, Department of Biostatistics, Epidemiology, and Informatics, Philadelphia, PA, United States of America 12 University of Pennsylvania, Division ...